Chinese Journal of Chromatography ›› 2024, Vol. 42 ›› Issue (4): 352-359.DOI: 10.3724/SP.J.1123.2024.02001
• Articles • Previous Articles Next Articles
SHAO Zhiyu, ZENG Jie, DONG Jun, LI Hongxia, YANG Ruiyue, CHEN Wenxiang, WANG Siming(
)
Received:2024-02-02
Online:2024-04-08
Published:2024-04-03
Supported by:CLC Number:
SHAO Zhiyu, ZENG Jie, DONG Jun, LI Hongxia, YANG Ruiyue, CHEN Wenxiang, WANG Siming. High performance liquid chromatography combined with the 2,2'-dithiodipyridine derivatization reaction for determination of different types of free thiols in human serum and analysis of their relationship with coronary heart disease[J]. Chinese Journal of Chromatography, 2024, 42(4): 352-359.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chrom-china.com/EN/10.3724/SP.J.1123.2024.02001
Fig. 2 Chromatograms of a serum sample before and after derivatization with 2,2'-DTDP a. non-derivatized serum sample; b. derivatized serum sample. Peak identifications: 1. 2-TP; 2. low-molecular-mass-S-S-pyridine (LMM-S-S-Pyr); 3. 2,2'-DTDP.
Fig. 3 Effects of (a) derivatization reagent concentration, (b) temperature, (c) reaction time, and (d) buffer pH on the peak areas of the analytes (n=3)
| Peak | Corresponding free thiol | Slope | Intercept | R | Linear range/ (μmol/L) | LOD/ (μmol/L) | LOQ/ (μmol/L) |
|---|---|---|---|---|---|---|---|
| 2-TP | Total-SH | 3058.66±40.29 | -139.57±14.64 | 0.9996±0.0002 | 31.25-1000 | 2.61 | 8.71 |
| LMM-S-S-Pyr | LMM-SH | 4022.68±86.76 | -138.12±39.01 | 0.9994±0.0002 | 31.25-1000 | 0.50 | 1.67 |
Table 1 Slopes, intercepts, correlation coefficients (R), linear ranges, limits of detection (LODs), and limits of quantification (LOQs) of the analytes (n=5)
| Peak | Corresponding free thiol | Slope | Intercept | R | Linear range/ (μmol/L) | LOD/ (μmol/L) | LOQ/ (μmol/L) |
|---|---|---|---|---|---|---|---|
| 2-TP | Total-SH | 3058.66±40.29 | -139.57±14.64 | 0.9996±0.0002 | 31.25-1000 | 2.61 | 8.71 |
| LMM-S-S-Pyr | LMM-SH | 4022.68±86.76 | -138.12±39.01 | 0.9994±0.0002 | 31.25-1000 | 0.50 | 1.67 |
| Peak | Corresponding free thiol | Sample | Background/ (μmol/L) | Added/ (μmol/L) | Detected/ (μmol/L) | Found*/ (μmol/L) | Recovery/ %(n=5) | Intra-day RSD/%(n=3) | Inter-day RSD/%(n=5) |
|---|---|---|---|---|---|---|---|---|---|
| 2-TP | Total-SH | serum 1 | 459.52 | 250 | 712.24 | 252.72 | 101.1 | 1.3 | 4.5 |
| 500 | 958.99 | 499.47 | 99.9 | 1.0 | 6.6 | ||||
| serum 2 | 392.53 | 250 | 648.18 | 255.65 | 102.3 | 2.8 | 4.8 | ||
| 500 | 919.60 | 527.07 | 105.4 | 2.9 | 7.6 | ||||
| LMM-S-S-Pyr | LMM-SH | serum 1 | 147.95 | 250 | 408.03 | 260.08 | 104.0 | 0.5 | 1.7 |
| 500 | 603.38 | 455.43 | 91.1 | 0.5 | 9.1 | ||||
| serum 2 | 110.94 | 250 | 375.86 | 264.92 | 106.0 | 1.0 | 2.3 | ||
| 500 | 566.82 | 455.88 | 91.2 | 0.4 | 8.3 |
Table 2 Spiked recoveries and precisions of the target compounds at two levels
| Peak | Corresponding free thiol | Sample | Background/ (μmol/L) | Added/ (μmol/L) | Detected/ (μmol/L) | Found*/ (μmol/L) | Recovery/ %(n=5) | Intra-day RSD/%(n=3) | Inter-day RSD/%(n=5) |
|---|---|---|---|---|---|---|---|---|---|
| 2-TP | Total-SH | serum 1 | 459.52 | 250 | 712.24 | 252.72 | 101.1 | 1.3 | 4.5 |
| 500 | 958.99 | 499.47 | 99.9 | 1.0 | 6.6 | ||||
| serum 2 | 392.53 | 250 | 648.18 | 255.65 | 102.3 | 2.8 | 4.8 | ||
| 500 | 919.60 | 527.07 | 105.4 | 2.9 | 7.6 | ||||
| LMM-S-S-Pyr | LMM-SH | serum 1 | 147.95 | 250 | 408.03 | 260.08 | 104.0 | 0.5 | 1.7 |
| 500 | 603.38 | 455.43 | 91.1 | 0.5 | 9.1 | ||||
| serum 2 | 110.94 | 250 | 375.86 | 264.92 | 106.0 | 1.0 | 2.3 | ||
| 500 | 566.82 | 455.88 | 91.2 | 0.4 | 8.3 |
| Variable | Total-SH | LMM-SH | P-SH |
|---|---|---|---|
| Gender | -0.014 | 0.079* | -0.034 |
| Age | -0.481*** | -0.026 | -0.480*** |
| SBP | -0.102** | -0.056 | -0.095* |
| FBG | 0.011 | -0.033 | 0.023 |
| TC | 0.073 | 0.027 | 0.068 |
| hsCRP | -0.117* | -0.044 | -0.111* |
| SOD | 0.856*** | 0.119** | 0.831*** |
| TMAO | -0.211*** | -0.059 | -0.200*** |
| LDH | -0.239*** | -0.001 | -0.243*** |
| BNP | -0.484*** | -0.061 | -0.473*** |
| cTnI | -0.278*** | -0.006 | -0.275*** |
| cTnT | -0.436*** | -0.140 | -0.447*** |
| Gensini score | -0.185*** | -0.016 | -0.185*** |
| CAD Classification | -0.096* | 0.054 | -0.117** |
Table 3 Nonparametric Spearman’s correlation coefficients of free thiols with clinical indicators and severity groups related to coronary heart disease (CAD)
| Variable | Total-SH | LMM-SH | P-SH |
|---|---|---|---|
| Gender | -0.014 | 0.079* | -0.034 |
| Age | -0.481*** | -0.026 | -0.480*** |
| SBP | -0.102** | -0.056 | -0.095* |
| FBG | 0.011 | -0.033 | 0.023 |
| TC | 0.073 | 0.027 | 0.068 |
| hsCRP | -0.117* | -0.044 | -0.111* |
| SOD | 0.856*** | 0.119** | 0.831*** |
| TMAO | -0.211*** | -0.059 | -0.200*** |
| LDH | -0.239*** | -0.001 | -0.243*** |
| BNP | -0.484*** | -0.061 | -0.473*** |
| cTnI | -0.278*** | -0.006 | -0.275*** |
| cTnT | -0.436*** | -0.140 | -0.447*** |
| Gensini score | -0.185*** | -0.016 | -0.185*** |
| CAD Classification | -0.096* | 0.054 | -0.117** |
|
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||